13, 2022, Vanegas JC, Afeiche MC, Gaskins AJ, et al
Losada E, Soldevila B, Ali MS, Martnez-Laguna D, Nogus X, Puig-Domingo M, et al
Results from Phase 2 trials were subsequently halted due to excessive rates of gastrointestinal adverse events leading to participant withdrawals
Cardiovascular Risk Management Since heart health is a key consideration during testosterone therapy, maintaining robust antioxidant defenses makes clinical sense
*Correspondence: Gerardo Ferrara, [email protected] This article was submitted to Skin Cancer, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Epub 2019 Aug 19